The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
 
Julia Katharina Schwarze
Honoraria - Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; MSD Belgium
 
Wietse Geens
No Relationships to Disclose
 
Jens Tijtgat
No Relationships to Disclose
 
Gil Awada
Employment - Abbott Laboratories (I)
Honoraria - Biocartis; Novartis
Consulting or Advisory Role - Novartis
Research Funding - Kom op tegen Kanker (Inst); Novartis (Inst); Stichting tegen Kanker (Inst)
 
Laura Seynaeve
No Relationships to Disclose
 
Anne-Marie Vanbinst
No Relationships to Disclose
 
Hendrik Everaert
No Relationships to Disclose
 
Alex Michotte
No Relationships to Disclose
 
Michaël Bruneau
No Relationships to Disclose
 
Ivan Van Riet
No Relationships to Disclose
 
Sandra Tuyaerts
No Relationships to Disclose
 
Johnny Duerinck
No Relationships to Disclose
 
Bart Neyns
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche
Speakers' Bureau - Novartis
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche